Want to see IN:ANURAS full AI Analyst Report?
ANURAS Stock Chart & Stats
₹1327.70
₹16.40(2.34%)
At close: 4:00 PM EST
₹1327.70
₹16.40(2.34%)
Day’s Range― - ―
52-Week Range₹1,047.40 - ₹1,415.40
Previous CloseN/A
Volume72.74K
Average Volume (3M)7.28K
Market Cap
₹143.82B
Enterprise Value₹162.12B
Total Cash (Recent Filing)₹4.44B
Total Debt (Recent Filing)₹12.23B
Price to Earnings (P/E)83.8
Beta0.59
Next Earnings
Jul 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.06%
Share Statistics
EPS (TTM)13.66
Shares Outstanding113,848,310
10 Day Avg. Volume10,749
30 Day Avg. Volume7,276
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)4.16
Price to Sales (P/S)5.87
P/FCF Ratio-38.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.45
Revenue Forecast (FY)₹20.03B
Bulls Say, Bears Say
Bulls Say
Revenue Recovery & ProfitabilityA clear revenue rebound and sustained mid-20s EBITDA margin indicate demand resilience and operational leverage in core specialty chemicals lines. Over 2–6 months this supports durable earnings, helps maintain customer confidence on supply continuity, and underpins reinvestment into complex synthesis capabilities.
B2B Custom-Synthesis ModelThe custom synthesis, contract-manufacturing model creates high technical barriers, customer-specific product specs, and long-term relationships. These elements generate stickiness, pricing power on complex molecules, and recurring revenue streams that are structurally durable across industry cycles.
Sizable Asset & Equity BaseA large asset base and meaningful equity provide capacity to fund scale-up, sustain multi-step manufacturing and absorb working-capital swings. This structural balance-sheet strength supports long-term contract fulfillment, capacity investments and shields operations from short-term liquidity shocks.
Bears Say
Negative Free Cash FlowPersistent negative free cash flow signals weak cash conversion despite accounting profits, implying reliance on external financing for capex and working-capital needs. Over months this limits financial flexibility, raises funding risk for growth projects, and can pressure credit metrics if not remediated.
Rising LeverageAn upward debt trend reduces buffer against margin shocks and raises interest-service obligations. If margins remain under pressure or cash flow stays weak, higher leverage will constrain strategic optionality, increase refinancing risk, and amplify downside in an adverse macro or commodity-cost environment.
Margin Compression Vs Prior YearsTrailing margins that have declined from prior peaks suggest structural mix shifts, competitive pricing, or cost pressures. Over the medium term this can curb return on invested capital and slow equity free-cash generation unless the company restores mix or operational efficiencies.
Anupam Rasayan India Ltd. News
ANURAS FAQ
What was Anupam Rasayan India Ltd.’s price range in the past 12 months?
Anupam Rasayan India Ltd. lowest stock price was ₹1047.40 and its highest was ₹1415.40 in the past 12 months.
What is Anupam Rasayan India Ltd.’s market cap?
Anupam Rasayan India Ltd.’s market cap is ₹143.82B.
When is Anupam Rasayan India Ltd.’s upcoming earnings report date?
Anupam Rasayan India Ltd.’s upcoming earnings report date is Jul 30, 2026 which is in 28 days.
How were Anupam Rasayan India Ltd.’s earnings last quarter?
Anupam Rasayan India Ltd. released its earnings results on May 23, 2026. The company reported ₹3.8 earnings per share for the quarter, beating the consensus estimate of ₹3.3 by ₹0.5.
Is Anupam Rasayan India Ltd. overvalued?
According to Wall Street analysts Anupam Rasayan India Ltd.’s price is currently Overvalued.
Does Anupam Rasayan India Ltd. pay dividends?
Anupam Rasayan India Ltd. pays a Annually dividend of ₹0.75 which represents an annual dividend yield of 0.06%. See more information on Anupam Rasayan India Ltd. dividends here
What is Anupam Rasayan India Ltd.’s EPS estimate?
Anupam Rasayan India Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anupam Rasayan India Ltd. have?
Anupam Rasayan India Ltd. has 113,848,310 shares outstanding.
What happened to Anupam Rasayan India Ltd.’s price movement after its last earnings report?
Anupam Rasayan India Ltd. reported an EPS of ₹3.8 in its last earnings report, beating expectations of ₹3.3. Following the earnings report the stock price went down -5.923%.
Which hedge fund is a major shareholder of Anupam Rasayan India Ltd.?
Currently, no hedge funds are holding shares in IN:ANURAS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Anupam Rasayan India Ltd.
Anupam Rasayan India Ltd., established in Surat, India, in 1984, specializes in the custom synthesis and production of specialty chemicals. The company manufactures a diverse range of life science-oriented chemicals, including intermediates and active ingredients crucial for the agrochemical sector, alongside compounds for antibacterial and ultraviolet protection applications in the personal care industry. Additionally, it provides essential intermediates and key starting materials vital for active pharmaceutical ingredients. Beyond these life science applications, Anupam Rasayan also supplies other specialized chemicals to various end-user segments, such as specialty pigments, dyes, and polymer additives. The company distributes its products both domestically and through exports.
Technical Analysis
Alkyl Amines Chemicals Limited
―
Garware Technical Fibres Limited
―
Jubilant Ingrevia Ltd.
―
Privi Speciality Chemicals Limited
―
Time Technoplast Limited
―